Mechanisms of antidiabetic effects of flavonoid rutin

被引:340
作者
Ghorbani, Ahmad [1 ]
机构
[1] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Iran
关键词
Diabetes; Flavonoids; Glucose; Lipids; Mechanism; Rutin; DIABETIC COMPLICATIONS; INSULIN REGULATION; OXIDATIVE STRESS; GLUCOSE-UPTAKE; ANTIOXIDANT; INHIBITION; QUERCETIN; PROTEIN; DYSFUNCTION; GLYCATION;
D O I
10.1016/j.biopha.2017.10.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Several lines of evidence suggest that flavonoids that originated from vegetables and medicinal plants have beneficial effects on diabetes by improving glycemic control, lipid profile, and antioxidant status. Rutin is a flavonoid found in many plants and shows a wide range of biological activities including anti-inflammatory, antioxidant, neuroprotective, nephroprotective, and hepatoprotective effects. In this review, the antihyperglycemic property of rutin and its protective effects against the development of diabetic complications are discussed. Proposed mechanisms for the antihyperglycemic effect of rutin include a decrease of carbohydrates absorption from the small intestine, inhibition of tissue gluconeogenesis, an increase of tissue glucose uptake, stimulation of insulin secretion from beta cells, and protecting Langerhans islet against degeneration. Rutin also decreases the formation of sorbitol, reactive oxygen species, advanced glycation end-product precursors, and inflammatory cytokines. These effects are considered to be responsible for the protective effect of rutin against hyperglycemia- and dyslipidemia-induced nephropathy, neuropathy, liver damage, and cardiovascular disorders. Taken together, the results of current experimental studies support the potential of rutin to prevent or treat pathologies associated with diabetes. Well-designed clinical studies are suggested to evaluate advantages and limits of rutin for managing diabetes.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 80 条
  • [1] Ahmed Osama Mohamed, 2010, Diabetologia Croatica, V39, P15
  • [2] Akondi RB, 2011, IRAN J PHARM RES, V10, P585
  • [3] Al-Roujeaie A., 2016, ANDROLOGIA, P1
  • [4] Alenazi MM, 2014, DIABETIC MED, V31, P57
  • [5] Alinejad B, 2013, AVICENNA J PHYTOMEDI, V3, P321
  • [6] Alsaif M. A., 2009, Pakistan Journal of Nutrition, V8, P745
  • [7] Amarapurkar D, 2002, Trop Gastroenterol, V23, P3
  • [8] Annapurna A, 2009, J PHARM PHARMACOL, V61, P1365, DOI [10.1211/jpp/61.10.0014, 10.1211/jpp.61.10.0014]
  • [9] [Anonymous], 2009, BMJ, DOI DOI 10.1136/BMJ.B4731
  • [10] Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes
    Arkkila, PET
    Koskinen, PJ
    Kantola, IM
    Rönnemaa, T
    Seppänen, E
    Viikari, JS
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 52 (02) : 113 - 118